These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33335879)

  • 41. Spatial and spatio-temporal epidemiological approaches to inform COVID-19 surveillance and control: a review protocol.
    Odhiambo JN; Dolan CB
    Syst Rev; 2022 Jul; 11(1):141. PubMed ID: 35836262
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improving Pandemic Response: Employing Mathematical Modeling to Confront Coronavirus Disease 2019.
    Biggerstaff M; Slayton RB; Johansson MA; Butler JC
    Clin Infect Dis; 2022 Mar; 74(5):913-917. PubMed ID: 34343282
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Memory is key in capturing COVID-19 epidemiological dynamics.
    Sofonea MT; Reyné B; Elie B; Djidjou-Demasse R; Selinger C; Michalakis Y; Alizon S
    Epidemics; 2021 Jun; 35():100459. PubMed ID: 34015676
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessing the quality of evidence from epidemiological agent-based models for the COVID-19 pandemic.
    Maziarz M; Zach M
    Hist Philos Life Sci; 2021 Jan; 43(1):10. PubMed ID: 33471199
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Rapid Reviews in the Time of COVID-19 - Experiences of the Competence Network Public Health COVID-19 and Proposal for a Standardized Procedure].
    Seidler A; Nußbaumer-Streit B; Apfelbacher C; Zeeb H;
    Gesundheitswesen; 2021 Mar; 83(3):173-179. PubMed ID: 33634462
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rapid review of available evidence on the serial interval and generation time of COVID-19.
    Griffin J; Casey M; Collins Á; Hunt K; McEvoy D; Byrne A; McAloon C; Barber A; Lane EA; More S
    BMJ Open; 2020 Nov; 10(11):e040263. PubMed ID: 33234640
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Forecasting emergence of COVID-19 variants of concern.
    Miller JK; Elenberg K; Dubrawski A
    PLoS One; 2022; 17(2):e0264198. PubMed ID: 35202422
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The unwanted legacies of COVID-19.
    Abbasi K
    J R Soc Med; 2021 Apr; 114(4):157. PubMed ID: 33899595
    [No Abstract]   [Full Text] [Related]  

  • 49. Features of databases that supported searching for rapid evidence synthesis during COVID-19: implications for future public health emergencies.
    Hagerman L; Clark EC; Neil-Sztramko SE; Colangeli T; Dobbins M
    BMC Med Res Methodol; 2024 Jun; 24(1):135. PubMed ID: 38907198
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Why COVID-19 models should incorporate the network of social interactions.
    Herrmann HA; Schwartz JM
    Phys Biol; 2020 Oct; 17(6):065008. PubMed ID: 32702678
    [TBL] [Abstract][Full Text] [Related]  

  • 51. How urban 'informality' can inform response to COVID-19: a research agenda for the future.
    Onditi F; Nyadera IN; Obimbo MM; Muchina SK
    Hist Philos Life Sci; 2021 Jan; 43(1):6. PubMed ID: 33433753
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Explaining the effective reproduction number of COVID-19 through mobility and enterprise statistics: Evidence from the first wave in Japan.
    Kajitani Y; Hatayama M
    PLoS One; 2021; 16(3):e0247186. PubMed ID: 33735174
    [TBL] [Abstract][Full Text] [Related]  

  • 53. One year of modeling and forecasting COVID-19 transmission to support policymakers in Connecticut.
    Morozova O; Li ZR; Crawford FW
    Sci Rep; 2021 Oct; 11(1):20271. PubMed ID: 34642405
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An interpretation of COVID-19 in Tokyo using a combination of SIR models.
    Maki K
    Proc Jpn Acad Ser B Phys Biol Sci; 2022; 98(2):87-92. PubMed ID: 35153271
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Missing science: A scoping study of COVID-19 epidemiological data in the United States.
    Bhatia R; Sledge I; Baral S
    PLoS One; 2022; 17(10):e0248793. PubMed ID: 36223335
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Concurrent emergencies: overlapping
    Prayoga W
    Front Public Health; 2024; 12():1331052. PubMed ID: 38741915
    [No Abstract]   [Full Text] [Related]  

  • 57. Why COVID-19 modelling of progression and prevention fails to translate to the real-world.
    Heneghan CJ; Jefferson T
    Adv Biol Regul; 2022 Dec; 86():100914. PubMed ID: 36182545
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Real-Time Infectious Disease Modeling to Inform Emergency Public Health Decision Making.
    Bershteyn A; Kim HY; Braithwaite RS
    Annu Rev Public Health; 2022 Apr; 43():397-418. PubMed ID: 34995131
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Descriptive understanding and prediction in COVID-19 modelling.
    Findl J; Suárez J
    Hist Philos Life Sci; 2021 Sep; 43(4):107. PubMed ID: 34546476
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An epidemiological modeling framework to inform institutional-level response to infectious disease outbreaks: a Covid-19 case study.
    Ma Z; Rennert L
    Sci Rep; 2024 Mar; 14(1):7221. PubMed ID: 38538693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.